Google's parent company Alphabet is forging ahead in the UK life sciences world in a tie-up with pharma giant Sanofi worth around $500m (£377m).
Hot on the heels of a partnership with GSK, Alphabet's Verily Life Sciences and Sanofi have launched a new company called Ondua to help treat Diabetes.
Verily, formerly part of Google's Life Sciences division before the creation of Alphabet, will combine its bioelectronics and analytics expertise with Sanofi's background in treatment.
"From monitoring food intake to testing glucose levels to actively seeking medical care, the challenges both on the physical and mental well-being of a person living with diabetes are incredibly difficult," said newly appointed Onduo chief executive Dr Joshua Riff
"We want to develop solutions that allow people living with diabetes to focus on the things they love and enjoy in life by providing tools to make dealing with their diabetes less burdensome."
Initially Onduo will develop a diabetes management platform focusing on type two diabetes, which accounts for more than 90 per cent of cases, but plans to address type one in future.